https://www.avient.com/products/long-fiber-technology/long-fiber-solutions/performance-additives
Work with our design team to customize a solution to meet your unique application requirements.
https://www.avient.com/news/advanced-technologies-and-sustainable-material-innovations-avient-debut-chinaplas-2024
ColorWorks™ Design and Technology Centers: an invaluable source of ideas, inspiration, and technical guidance provided by a dedicated team of experts to establish high-impact color concepts at the earliest stages of product development in close collaboration with customers at four global centers
How Avient Can Help with Metal Replacement for Applications in the Healthcare Industry: presented by Catherine Hu, Senior Marketing Specialist from Specialty Engineered Materials Asia, April 24 at 1:50 pm
https://www.avient.com/sites/default/files/2024-06/CM Europe Ltd Modern_Slavery_Statement - 2024 V4.pdf
Our effectiveness in combating slavery and human trafficking
In 2024 the following key performance indicators (KPIs) will be used to measure how effective we have been in ensuring that slavery
and human trafficking is not taking place in any part of our business or supply chains
100% completion of the Code of Conduct for all associates
Page 3 of 3
Our on-going commitment
As part of our modern slavery strategy we will continue to monitor the progress we have made and build on our achievements and
initiatives in the next financial year.
Our procurement and compliance teams will continue to focus on identifying and addressing any
potential risks in our supply chain and the business will continue to provide awareness and training to all of its employees.
https://www.avient.com/sites/default/files/2022-08/ColorMatrix Excelite Product Bulletin.pdf
HOW IT WORKS
Excelite additives typically contain 70%wt of active
chemical foaming agent (CFA), dispersed in a liquid
carrier, thus promoting greater product efficiency.
EXCELITE VS POWDER
• Enables a greater level of density control, through
consistent distribution in the polymer
• Simplifies and optimizes resin compounding
capabilities (PVC dry blends)
• Enables greater control over foaming and expands
processing window when re-introducing regrind
• Clean and highly accurate dosing process, with
fewer of the health and safety concerns that can
become apparent with powder CFAs
EXCELITE VS PELLET
• Being significantly more concentrated, Excelite additive enables lower total cost to foam
• Can achieve lower density, less carrier influence
• Finer and tighter cell structure through better additive distribution
• Improved linear consistency of cell structure as ColorMatrix pumps continually meter output,
giving greater stability over material dosing
• Improved plant working capital as lower let down ratios means less material is consumed and
reduces inventory holdings
TECHNICAL SUPPORT
• Avient has a market leading service team which understands
foaming processes, we assist customers to deliver performance
and production efficiencies with Excelite™ technology
• Please contact your local Avient representative for additional
information on our line of foaming additives
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives_Laser Welding Additives for Medical Devices Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Available as additive concentrates, ready-to-use
additive formulations or ready-to-use additive/
colorant formulations for different polymers
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request; exceptions may occur
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/investors/investor-news?page=16
Breaking news and information about Avient earnings, innovations, investor events, acquisitions, and the newest members of our team are available below, searchable by keyword and by date.
https://www.avient.com/investors/investor-news?page=18
Breaking news and information about Avient earnings, innovations, investor events, acquisitions, and the newest members of our team are available below, searchable by keyword and by date.
https://www.avient.com/investors/investor-news?page=1
Breaking news and information about Avient earnings, innovations, investor events, acquisitions, and the newest members of our team are available below, searchable by keyword and by date.
https://www.avient.com/investors/investor-news?page=12
Breaking news and information about Avient earnings, innovations, investor events, acquisitions, and the newest members of our team are available below, searchable by keyword and by date.
https://www.avient.com/investors/investor-news
Breaking news and information about Avient earnings, innovations, investor events, acquisitions, and the newest members of our team are available below, searchable by keyword and by date.